乳房温存手術の市場規模、シェア、動向分析レポート：手技別、製品別、最終用途別、地域別、セグメント予測、2025年～2033年

乳房温存手術市場の概要

乳房温存手術の世界市場規模は2024年に24億5,000万米ドルと推定され、2033年には45億8,000万米ドルに達すると予測され、2025～2033年のCAGRは7.26%で成長します。この成長の背景には、乳がん罹患率の上昇と早期発見・早期介入が重視されるようになっていることがあります。

美容的な外観と乳房機能の両方を維持する手術に対する患者の嗜好が高まっており、侵襲性の低い手術オプションへの需要が高まっています。例えば、米国がん協会の報告書によると、2024年には米国の女性の間で浸潤性乳がんの推定310,720症例とin situ乳管がん（DCIS）の推定5万6,500症例が新たに診断されると予想されています。美容的・機能的温存への嗜好の高まりが、乳房温存手術（BCS）市場の成長を牽引しています。

乳房を完全に切除する従来型乳房切除術とは異なり、BCSでは腫瘍を切除する一方で、できるだけ自然な乳房組織や外観を残すことに重点を置いています。このアプローチは、がんを効果的に治療するだけでなく、身体的な美しさ、身体イメージ、生活の質も維持する手術に対する患者、特に若い女性からの需要の高まりに沿ったものです。感覚が保たれ、身体的外傷が少ないといった機能的な利点は、精神的な幸福や術後の満足感の向上に寄与します。

乳がんの有病率の上昇は、外科的介入を必要とする患者数を直接的に増加させるため、BCS市場の主要促進要因となっています。認知度の向上、検診プログラムの普及、診断技術の進歩により、より多くの乳がんが早期段階で発見されるようになり、乳房全摘術ではなく乳房温存術の対象となる患者の割合が増えています。早期診断がより良い治療成績を支えるだけでなく、乳房の外観と機能を維持する侵襲の少ない治療に対する患者の嗜好の高まりとも一致しています。乳がんの世界の負担が増加し続ける中、ヘルスケアシステムはBCSを標準的な治療経路に組み込む傾向を強めており、特殊な手術器具、局在化技術、術後ケアソリューションに対する需要を煽っています。

ワイヤレス定位とAIベースマージン評価における技術の進歩は、乳房温存手術（BCS）市場に革命をもたらし、手術精度を大幅に向上させ、再手術率を低減し、患者の転帰を向上させています。従来は、腫瘍部位をピンポイントで特定するためにワイヤガイドによる位置決めが行われていたが、この方法には、患者の不快感、スケジュールの制約、ワイヤのずれのリスクなど、いくつかの課題がありました。対照的に、ワイヤレス定位システム（RFIDや磁気シードベース技術など）は、柔軟性が高く、精度が向上し、患者と外科医の双方にとって全体的な手術経験が向上します。

同時に、AIを搭載したマージン評価ツールは、術中の意思決定に変革をもたらしつつあります。これらの技術はリアルタイムで組織サンプルを分析し、手術断端にがん細胞が残っているかどうかを判定します。これにより、再手術の必要性が大幅に減少し、回復時間が短縮され、臨床効率が向上します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 乳房温存手術市場の変数、動向、範囲

• 市場系統の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 乳房温存手術市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 乳房温存手術市場：手技別、推定・動向分析

• セグメントダッシュボード
• 乳房温存手術市場：手技変動分析と市場シェア、2024年と2033年
• 乳房切除術
• 四分円切除術
• 部分乳房切除術

第5章 乳房温存手術市場：製品別、推定・動向分析

• セグメントダッシュボード
• 乳房温存手術市場：製品変動分析と市場シェア、2024年と2033年
• 腫瘍局在化デバイス
  • ワイヤガイドによる位置特定
  • 磁気シードの位置特定
  • レーダーベース位置特定
  • その他
• 外科的切除デバイス
  • 電気外科ユニット/デバイス
  • メス/鉗子/開創器/クランプ
  • 真空アシスト生検システム
  • その他
• マージン評価デバイス
• 術中画像とナビゲーションデバイス

第6章 乳房温存手術市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 乳房温存手術市場：最終用途変動分析と市場シェア、2024年と2033年
• 病院
• 外来手術センター
• 腫瘍学/専門クリニック
• その他

第7章 乳房温存手術市場：製品、手技、最終用途による地域別、推定・動向分析

• 地域展望
• 乳房温存手術市場：地域変動分析と市場シェア、2024年と2033年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Hologic, Inc
  • Dilon Technologies
  • Argon Medical Devices
  • Merit Medical Systems
  • KUBTEC
  • Stryker
  • SamanTree Medical
  • Perimeter Medical Imaging AI
  • Xeos
  • BD
  • Mammotome（Danaher）
  • CairnSurgical Inc.
  • Innoblative Designs
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェア予測分析

List of Tables

• Table 1 List of abbreviations
• Table 2 Global breast-conserving surgery market, by region, 2021 - 2033 (USD Million)
• Table 3 Global breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 4 Global breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 5 Global breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 6 North America breast-conserving surgery market, by country, 2021 - 2033 (USD Million)
• Table 7 North America breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 8 North America breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 9 North America breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 10 U.S. breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 11 U.S. breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 12 U.S. breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 13 Canada breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 14 Canada breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 15 Canada breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 16 Mexico breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 17 Mexico breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 18 Mexico breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 19 Europe breast-conserving surgery market, by country, 2021 - 2033 (USD Million)
• Table 20 Europe breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 21 Europe breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 22 Europe breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 23 UK breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 24 UK breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 25 UK breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 26 Germany breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 27 Germany breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 28 Germany breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 29 France breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 30 France breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 31 France breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 32 Italy breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 33 Italy breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 34 Italy breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 35 Spain breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 36 Spain breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 37 Spain breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 38 Denmark breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 39 Denmark breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 40 Denmark breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 41 Sweden breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 42 Sweden breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 43 Sweden breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 44 Norway breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 45 Norway breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 46 Norway breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 47 Asia Pacific breast-conserving surgery market, by country, 2021 - 2033 (USD Million)
• Table 48 Asia Pacific breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 49 Asia Pacific breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 50 Asia Pacific breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 51 China breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 52 China breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 53 China breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 54 Japan breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 55 Japan breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 56 Japan breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 57 India breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 58 India breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 59 India breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 60 South Korea breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 61 South Korea breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 62 South Korea breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 63 Australia breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 64 Australia breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 65 Australia breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 66 Thailand breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 67 Thailand breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 68 Thailand breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 69 Latin America breast-conserving surgery market, by country, 2021 - 2033 (USD Million)
• Table 70 Latin America breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 71 Latin America breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 72 Latin America breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 73 Brazil breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 74 Brazil breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 75 Brazil breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 76 Argentina breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 77 Argentina breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 78 Argentina breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 79 MEA breast-conserving surgery market, by country, 2021 - 2033 (USD Million)
• Table 80 MEA breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 81 MEA breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 82 MEA breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 83 South Africa breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 84 South Africa breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 85 South Africa breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 86 Saudi Arabia breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 87 Saudi Arabia breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 88 Saudi Arabia breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 89 UAE breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 90 UAE breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 91 UAE breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)
• Table 92 Kuwait breast-conserving surgery market, by product, 2021 - 2033 (USD Million)
• Table 93 Kuwait breast-conserving surgery market, By procedure, 2021 - 2033 (USD Million)
• Table 94 Kuwait breast-conserving surgery market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Breast-conserving surgery market segmentation
• Fig. 3 Market research process
• Fig. 4 Information procurement process
• Fig. 5 Primary research pattern
• Fig. 6 Breast-conserving surgery market snapshot, 2024 (USD Million)
• Fig. 7 Segment snapshot, USD Million
• Fig. 8 Competitive landscape snapshot
• Fig. 9 Penetration & growth prospect mapping, by distribution channel
• Fig. 10 Market driver analysis (Current & future impact)
• Fig. 11 Market restraint analysis (Current & future impact)
• Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 13 Lumpectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 Quadrantectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 15 Segmental mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 16 Tumor localization devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 17 Wire-guided localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 18 Magnetic seed localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Radar-based localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Surgical excision devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Electrosurgical units/devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Scalpels/forceps/retractors/clamps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Vacuum-assisted biopsy systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Margin assessment devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Intraoperative imaging & navigation devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Oncology/specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Breast-conserving surgery market: Regional key takeaways (USD Million)
• Fig. 33 Breast-conserving surgery market: Regional outlook, 2023 & 2033, USD Million
• Fig. 34 North America breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 U.S. breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Canada breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Mexico breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 Europe breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 39 UK breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 40 Germany breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 France breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Spain breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Italy breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Sweden breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 45 Norway breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Denmark breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 47 Asia Pacific breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 China breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Japan breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 India breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 51 South Korea breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 52 Australia breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 53 Thailand breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Latin America breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 55 Brazil breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Argentina breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 57 Middle East and Africa breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 South Africa breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 59 Saudi Arabia breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 UAE breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 61 Kuwait breast-conserving surgery market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 List of key emerging companies
• Fig. 63 Company market share analysis, 2024
• Fig. 64 Market differentiators
• Fig. 65 Competitive dashboard analysis
• Fig. 66 Regional network map

Breast-conserving Surgery Market Summary

The global breast-conserving surgery market size was estimated at USD 2.45 billion in 2024 and is projected to reach USD 4.58 billion by 2033, growing at a CAGR of 7.26% from 2025 to 2033. The growth is attributed to the rising incidence of breast cancer and a growing emphasis on early detection and intervention.

There is an increasing preference among patients for procedures that preserve both cosmetic appearance and breast function, driving demand for less invasive surgical options. For instance, according to a report by the American Cancer Society, in 2024, an estimated 310,720 new cases of invasive breast cancer and 56,500 cases of ductal carcinoma in situ (DCIS) are expected to be diagnosed among women in the U.S. Additionally, 42,250 women are projected to lose their lives to breast cancer. The rising preference for cosmetic and functional preservation drives growth in the breast-conserving surgery (BCS) market.

Unlike traditional mastectomy, which involves the complete removal of the breast, BCS focuses on excising the tumor while retaining as much of the natural breast tissue and appearance as possible. This approach aligns with the increasing demand from patients, especially younger women, for procedures that not only treat cancer effectively but also maintain physical aesthetics, body image, and quality of life. Functional benefits such as preserved sensation and less physical trauma contribute to improved emotional well-being and postoperative satisfaction.

The rising prevalence of breast cancer is a primary driver of the BCS market, as it directly increases the number of patients requiring surgical intervention. With improved awareness, widespread screening programs, and advancements in diagnostic technologies, more breast cancers are being detected at earlier stages-making a larger proportion of patients eligible for breast-conserving procedures instead of full mastectomy. Early-stage diagnosis not only supports better outcomes but also aligns with growing patient preferences for less invasive treatments that preserve breast appearance and function. As the global burden of breast cancer continues to rise, healthcare systems are increasingly integrating BCS into standard care pathways, fueling demand for specialized surgical tools, localization technologies, and post-operative care solutions.

Technological advancements in wireless localization and AI-based margin assessment are revolutionizing the breast-conserving surgery (BCS) market, significantly improving surgical precision, reducing reoperation rates, and enhancing patient outcomes. Traditionally, wire-guided localization was used to pinpoint tumor sites, but this method posed several challenges, such as patient discomfort, scheduling constraints, and the risk of wire displacement. In contrast, wireless localization systems (e.g., RFID or magnetic seed-based technologies) offer greater flexibility, improved accuracy, and a better overall surgical experience for both patients and surgeons.

Simultaneously, AI-powered margin assessment tools are transforming intraoperative decision-making. These technologies analyze tissue samples in real-time to determine if cancerous cells remain at the surgical margins, allowing surgeons to make immediate adjustments and achieve clean margins during the first procedure. This greatly reduces the need for second surgeries, shortens recovery time, and improves clinical efficiency.

Global Breast-conserving Surgery Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast-conserving surgery market report on the basis of procedure, product, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Lumpectomy
• Quadrantectomy
• Segmental Mastectomy
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Tumor Localization Devices
  • Wire-guided localization
  • Magnetic seed localization
  • Radar-based localization
  • Others
• Surgical Excision Devices
  • Electrosurgical units/devices
  • Scalpels/forceps/retractors/clamps
  • Vacuum-assisted biopsy systems
  • Others
• Margin Assessment Devices
• Intraoperative Imaging & Navigation Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Oncology/Specialty Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast-Conserving Surgery Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing breast cancer incidence and focus on early detection
    • 3.2.1.2. Rising preference for cosmetic and functional preservation
    • 3.2.1.3. Technological advancement in wireless localization and AI-based margin assessment
    • 3.2.1.4. Growth of ambulatory surgical settings
    • 3.2.1.5. Favorable government and reimbursement support in developed nations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of advanced technologies
    • 3.2.2.2. Limited access to early diagnosis
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Breast-Conserving Surgery Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Breast-Conserving Surgery Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Breast-Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
• 4.3. Lumpectomy
  • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Quadrantectomy
  • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Segmental Mastectomy
  • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast-Conserving Surgery Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Breast-Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
• 5.3. Tumor Localization Devices
  • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Wire-Guided Localization
    • 5.3.2.1. Wire-guided localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.3. Magnetic Seed Localization
    • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.4. Radar-Based Localization
    • 5.3.4.1. Radar-based localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.5. Others
    • 5.3.5.1. Others market estimates and forecasts 2018 to 2033 (USD Million)
• 5.4. Surgical Excision Devices
  • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)
  • 5.4.2. Electrosurgical Units/Devices
    • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.3. Scalpels/Forceps/Retractors/Clamps
    • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.4. Vacuum-Assisted Biopsy Systems
    • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.5. Other
    • 5.4.5.1. Other market estimates and forecasts 2018 to 2033 (USD Million)
• 5.5. Margin Assessment Devices
  • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)
• 5.6. Intraoperative Imaging & Navigation Devices
  • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)

Chapter 6. Breast-Conserving Surgery Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Breast-Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Ambulatory Surgery Centers
  • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Oncology/Specialty Clinics
  • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast-Conserving Surgery Market: Regional Estimates & Trend Analysis by Product, Procedure, End Use

• 7.1. Regional Outlook
• 7.2. Breast-Conserving Surgery Market: Regional Movement Analysis & Market Share, 2024 & 2033
• 7.3. North America
  • 7.3.1. North America Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Mexico Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Argentina Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Hologic, Inc
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Dilon Technologies
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Argon Medical Devices
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Merit Medical Systems
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. KUBTEC
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Stryker
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. SamanTree Medical
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Perimeter Medical Imaging AI
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Xeos
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. BD
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Mammotome (Danaher)
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Product Benchmarking
    • 8.2.11.4. Strategic Initiatives
  • 8.2.12. CairnSurgical Inc.
    • 8.2.12.1. Company Overview
    • 8.2.12.2. Financial Performance
    • 8.2.12.3. Product Benchmarking
    • 8.2.12.4. Strategic Initiatives
  • 8.2.13. Innoblative Designs
    • 8.2.13.1. Company Overview
    • 8.2.13.2. Financial Performance
    • 8.2.13.3. Product Benchmarking
    • 8.2.13.4. Strategic Initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2024